Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Pulmonary arterial hypertension (PAH) is a progressive disease caused by increased pulmonary artery pressure and pulmonary vascular resistance, eventually leading to right heart failure until death. Soluble guanylate cyclase (sGC) has been regarded as an attractive drug target in treating PAH. In th...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Frontiers in Pharmacology
المؤلفون الرئيسيون: Yi Tong, Qian Jiao, Yuanru Liu, Jiankun Lv, Rui Wang, Lili Zhu
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Frontiers Media S.A. 2018-09-01
الموضوعات:
pulmonary arterial hypertension
soluble guanylate cyclase
maprotiline
human pulmonary artery smooth muscle cells
hypoxia
الوصول للمادة أونلاين:https://www.frontiersin.org/article/10.3389/fphar.2018.01032/full

الانترنت

https://www.frontiersin.org/article/10.3389/fphar.2018.01032/full

مواد مشابهة